| 摘要 |
The use of a Herpes Simplex Virus (HSV) or HSV Virus Like Particle (VLP) to express one or more non-HSV antigens, wherein said non HSV antigens comprises a cancer antigen, a Human Cytomegalovirus (HCMV) polyepitope or an Epstein-Barr Virus (EBV) polyepitope. |
